NEW PUBLISHED ARTICLE: Everard et al., 2024
๐
๐๐ญ๐ญ๐ฒ ๐๐๐ข๐ ๐จ๐ฑ๐ข๐๐๐ญ๐ข๐จ๐ง (๐
๐๐) ๐๐ข๐ฌ๐จ๐ซ๐๐๐ซ๐ฌ are autosomal recessive genetic disorders affecting either the transport or the oxidation of fatty acids. Undiagnosed FAO disorders are responsible of ๐ฌ๐๐ฏ๐๐ซ๐ ๐ง๐๐ฎ๐ซ๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐ข๐ฆ๐ฉ๐๐ข๐ซ๐ฆ๐๐ง๐ญ in patients. In this article, the authors investigated the impact of ๐ง๐๐ฐ๐๐จ๐ซ๐ง ๐ฌ๐๐ซ๐๐๐ง๐ข๐ง๐ (๐๐๐) for FAO disorders on neurological outcome of patients.
In this ๐ซ๐๐ญ๐ซ๐จ๐ฌ๐ฉ๐๐๐ญ๐ข๐ฏ๐ ๐๐ง๐ ๐ฆ๐ฎ๐ฅ๐ญ๐ข๐๐๐ง๐ญ๐ซ๐ข๐ ๐ฌ๐ญ๐ฎ๐๐ฒ, the data of 54 patients with FAO disorders were collected. Overall, 64.8% patients were diagnosed after NBS, 31.5% patients on clinical presentation, and 3.7% patients after family screening. ๐๐๐ซ๐ข๐จ๐ฎ๐ฌ ๐๐๐๐ข๐๐ข๐๐ง๐๐ข๐๐ฌ ๐ฐ๐๐ซ๐ ๐ข๐๐๐ง๐ญ๐ข๐๐ข๐๐, such as medium-chain acyl-CoA dehydrogenase deficiency, very long-chain acyl-CoA dehydrogenase deficiency, etc.
The neurological outcome of 25 patients with FAO after NBS results was compared with that of the patients diagnosed on clinical presentation. Further investigations are required to better understand the physiopathology of long-term complications to improve the quality of life of patients and ensure optimal management. The article is already available on the journal's website! DOI: http:/doi.org/10.1016/j.ejpn.2024.02.003